Revisão Cochrane: Plasma convalescente e imunoglobulina hiperimune em Covid-19

A eficácia e segurança do plasma convalescente para o tratamento do Covid-19 continua incerta. Novos estudos serão acrescentados na medida em que forem surgindo nesta revisão sistemática viva (LSR; living systematic review)

Fonte:

Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review – Cochrane Library

Comentário:

Convalescent plasma to treat people with COVID-19: the evidence so far – Evidently Cochrane

Commentário relacionado no Twitter

What do we know about convalescent plasma as a possible treatment for #COVID19? https://t.co/VZgPyW5HJy The @CochraneHaem living systematic review has now been updated, but uncertainty remains about the possible benefits & harms of #plasma. @CochraneUK's @SarahChapman30 explains. pic.twitter.com/9RQi6sDFV9

— Cochrane UK (@CochraneUK) July 10, 2020